A Study of Clofarabine and Cytarabine for Older Patients With Relapsed or Refractory Acute Myelogenous Leukemia (AML)(CLASSIC I)
Clinical trial NCT00317642 · COMPLETED
Trial details
- NCT number
- NCT00317642
- Sponsor
- Genzyme, a Sanofi Company
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2006-08-01
- Primary completion
- 2012-01-01
- Enrollment
- 326
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.